Catalyst Pharmaceuticals (CPRX) Change in Inventory (2019 - 2026)

Catalyst Pharmaceuticals' Change in Inventory history runs 8 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

• Quarterly Change in Inventory fell 1043.46% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.6 million (up 9023.43% YoY) and the FY2025 annual result came in at $18.1 million, up 364.18% from the prior year.
• Change in Inventory was -$2.2 million for Q1 2026 at Catalyst Pharmaceuticals, down from $9.2 million in the prior quarter.
• Across five years, Change in Inventory topped out at $9.2 million in Q4 2025 and bottomed at -$2.2 million in Q1 2026.
• A 5-year average of $1.4 million and a median of -$43000.0 in 2022 frame the typical range for Change in Inventory.
• Peak annual rise in Change in Inventory reached 2121.1% in 2023, while the deepest fall reached 1241.86% in 2023.
• Catalyst Pharmaceuticals' Change in Inventory stood at -$327000.0 in 2022, then jumped by 2121.1% to $6.6 million in 2023, then tumbled by 107.2% to -$476000.0 in 2024, then surged by 2036.97% to $9.2 million in 2025, then slumped by 124.25% to -$2.2 million in 2026.
• Business Quant data shows CPRX's Change in Inventory at -$2.2 million in Q1 2026, $9.2 million in Q4 2025, and $9.1 million in Q3 2025.